24 August 2018 - Demonstrated tolerability and efficacy of a tretinoin in first and only once daily lotion formulation.

Ortho Dermatologics today announced that the U.S. FDA has approved the new drug application for Altreno (tretinoin 0.05%) lotion, indicated for the topical treatment of acne vulgaris in patients 9 years of age and older.

Altreno is the first formulation of tretinoin in a lotion, and has been shown to be effective and generally well-tolerated. Altreno is expected to be available during the fourth quarter of 2018.

Read Ortho Dermatologics press release